Trials / Enrolling By Invitation
Enrolling By InvitationNCT04762862
QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
"Precision medicine and targeted therapies have played a crucial role over the past ten years in the personalized care of cancer patients. In this retrospective and observational study, we focused on patients for which no standard or curative treatment was available and for which the management was discussed in a Molecular Tumor Board (MTB). The role of the MTB is to decide the most appropriate therapeutic options for patients according to the potential identification of molecular targets. Among the analyses carried out, we focused on a quantitative genome-wide analysis: the CGH/SNP-array (Comparative Genomic Hybridization / Single Nucleotide Polymorphism on array). The objective was to evaluate the impact of CGH/SNP-array analyses in the identification of targeted molecular alterations. "
Conditions
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2026-08-31
- Completion
- 2026-12-31
- First posted
- 2021-02-21
- Last updated
- 2025-04-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04762862. Inclusion in this directory is not an endorsement.